These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 15961717)

  • 1. Inhibition of Rho-kinase attenuates hypoxia-induced angiogenesis in the pulmonary circulation.
    Hyvelin JM; Howell K; Nichol A; Costello CM; Preston RJ; McLoughlin P
    Circ Res; 2005 Jul; 97(2):185-91. PubMed ID: 15961717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attenuation of acute hypoxic pulmonary vasoconstriction and hypoxic pulmonary hypertension in mice by inhibition of Rho-kinase.
    Fagan KA; Oka M; Bauer NR; Gebb SA; Ivy DD; Morris KG; McMurtry IF
    Am J Physiol Lung Cell Mol Physiol; 2004 Oct; 287(4):L656-64. PubMed ID: 14977625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rho/Rho kinase signaling mediates increased basal pulmonary vascular tone in chronically hypoxic rats.
    Nagaoka T; Morio Y; Casanova N; Bauer N; Gebb S; McMurtry I; Oka M
    Am J Physiol Lung Cell Mol Physiol; 2004 Oct; 287(4):L665-72. PubMed ID: 12959926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of RhoA/Rho kinase signaling in pulmonary hypertension of the fawn-hooded rat.
    Nagaoka T; Gebb SA; Karoor V; Homma N; Morris KG; McMurtry IF; Oka M
    J Appl Physiol (1985); 2006 Mar; 100(3):996-1002. PubMed ID: 16322374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pathophysiological basis of chronic hypoxic pulmonary hypertension in the mouse: vasoconstrictor and structural mechanisms contribute equally.
    Cahill E; Rowan SC; Sands M; Banahan M; Ryan D; Howell K; McLoughlin P
    Exp Physiol; 2012 Jun; 97(6):796-806. PubMed ID: 22366565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhaled Rho kinase inhibitors are potent and selective vasodilators in rat pulmonary hypertension.
    Nagaoka T; Fagan KA; Gebb SA; Morris KG; Suzuki T; Shimokawa H; McMurtry IF; Oka M
    Am J Respir Crit Care Med; 2005 Mar; 171(5):494-9. PubMed ID: 15563635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of sustained hypoxic vasoconstriction by Y-27632 in isolated intrapulmonary arteries and perfused lung of the rat.
    Robertson TP; Dipp M; Ward JP; Aaronson PI; Evans AM
    Br J Pharmacol; 2000 Sep; 131(1):5-9. PubMed ID: 10960061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of RhoA/ROCK signaling pathway ameliorates hypoxic pulmonary hypertension via HIF-1α-dependent functional TRPC channels.
    Wang XY; Mo D; Tian W; Liu XX; Zhou YG; Sun Y; Feng YD; Xiao X; Hao XW; Zhang HN; Li C; Cao W; Li XQ
    Toxicol Appl Pharmacol; 2019 Apr; 369():60-72. PubMed ID: 30831131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of rho kinase attenuates high flow induced pulmonary hypertension in rats.
    Li FH; Xia W; Li AW; Zhao CF; Sun RP
    Chin Med J (Engl); 2007 Jan; 120(1):22-9. PubMed ID: 17254483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. L-Arginine promotes angiogenesis in the chronically hypoxic lung: a novel mechanism ameliorating pulmonary hypertension.
    Howell K; Costello CM; Sands M; Dooley I; McLoughlin P
    Am J Physiol Lung Cell Mol Physiol; 2009 Jun; 296(6):L1042-50. PubMed ID: 19346433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rho kinase activation maintains high pulmonary vascular resistance in the ovine fetal lung.
    Parker TA; Roe G; Grover TR; Abman SH
    Am J Physiol Lung Cell Mol Physiol; 2006 Nov; 291(5):L976-82. PubMed ID: 16815887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelin-1 and serotonin are involved in activation of RhoA/Rho kinase signaling in the chronically hypoxic hypertensive rat pulmonary circulation.
    Homma N; Nagaoka T; Morio Y; Ota H; Gebb SA; Karoor V; McMurtry IF; Oka M
    J Cardiovasc Pharmacol; 2007 Dec; 50(6):697-702. PubMed ID: 18091588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rho kinase-mediated vasoconstriction is important in severe occlusive pulmonary arterial hypertension in rats.
    Oka M; Homma N; Taraseviciene-Stewart L; Morris KG; Kraskauskas D; Burns N; Voelkel NF; McMurtry IF
    Circ Res; 2007 Mar; 100(6):923-9. PubMed ID: 17332430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxia and Rho/Rho-kinase signaling. Lung development versus hypoxic pulmonary hypertension.
    McMurtry IF; Bauer NR; Fagan KA; Nagaoka T; Gebb SA; Oka M
    Adv Exp Med Biol; 2003; 543():127-37. PubMed ID: 14713118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of responses to the Rho-kinase inhibitor Y-27632 in the pulmonary and systemic vascular bed of the rat.
    Casey DB; Badejo AM; Dhaliwal JS; Sikora JL; Fokin A; Golwala NH; Greco AJ; Murthy SN; Nossaman BD; Hyman AL; Kadowitz PJ
    Am J Physiol Heart Circ Physiol; 2010 Jul; 299(1):H184-92. PubMed ID: 20435851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term inhibition of Rho kinase with fasudil attenuates high flow induced pulmonary artery remodeling in rats.
    Li F; Xia W; Li A; Zhao C; Sun R
    Pharmacol Res; 2007 Jan; 55(1):64-71. PubMed ID: 17127075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dexfenfluramine discontinuous treatment does not worsen hypoxia-induced pulmonary vascular remodeling but activates RhoA/ROCK pathway: consequences on pulmonary hypertension.
    Desbuards N; Antier D; Rochefort GY; Apfeldorfer CS; Schenck E; Hanton G; Hyvelin JM
    Eur J Pharmacol; 2009 Jan; 602(2-3):355-63. PubMed ID: 19049806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defective RhoA/Rho-kinase signaling contributes to vascular hypocontractility and vasodilation in cirrhotic rats.
    Hennenberg M; Biecker E; Trebicka J; Jochem K; Zhou Q; Schmidt M; Jakobs KH; Sauerbruch T; Heller J
    Gastroenterology; 2006 Mar; 130(3):838-54. PubMed ID: 16530523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Congenital erythropoietin over-expression causes "anti-pulmonary hypertensive" structural and functional changes in mice, both in normoxia and hypoxia.
    Weissmann N; Manz D; Buchspies D; Keller S; Mehling T; Voswinckel R; Quanz K; Ghofrani HA; Schermuly RT; Fink L; Seeger W; Gassmann M; Grimminger F
    Thromb Haemost; 2005 Sep; 94(3):630-8. PubMed ID: 16268482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rho kinase-mediated vasoconstriction in pulmonary hypertension.
    McMurtry IF; Abe K; Ota H; Fagan KA; Oka M
    Adv Exp Med Biol; 2010; 661():299-308. PubMed ID: 20204738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.